News
Tourmaline Bio is well-funded, with cash runway into 2H 2027, minimizing near-term dilution risk for investors. Click here to ...
The signaling molecule IL-6, involved in inflammation, is associated with increasing frailty in relapsing-remitting MS, a ...
Q1 2025 Earnings Conference Call May 9, 2025 10:00 AM ETCompany ParticipantsJustine Koenigsberg - Vice President ...
Discover early autoimmune warning signs doctors miss, from unusual fatigue to distinctive pain patterns and surprising skin ...
DDF treatment resulted in a reduction in pro-inflammatory cytokines, including interleukins IL-6 and IL-1β, and tumor necrosis factor alpha (TNF-α), which are typically elevated during inflammatory ...
Epileptogenesis involves complex mechanisms, including inflammation and apoptosis. Rosiglitazone, a peroxisome ...
Aging impairs adipose tissue function and contributes to metabolic disorders, such as obesity and insulin resistance. Chronic inflammation is mediated by cytokines, including IL-6, IL-1β, and TNF-α, ...
Researchers also studied inflammatory markers like interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and C-reactive protein. Chronic inflammation has long been suspected as playing a ...
The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April ...
announced that data from the Phase 2a clinical trial of its oral TNF-alpha inhibitor drug candidate isomyosamine was presented last week in a podium session at the peer-reviewed 15th International ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results